Skip to content
Home/Companies/Biotech/Breath Therapeutics
BT

Breath Therapeutics

Biotech·Germany·Exited 2019·Held 3yr

Breath Therapeutics is a healthcare / biotech company, headquartered in Germany.

Entry
2016
Hold
3yr
Exit
2019
Est. EV
–

Who owns Breath Therapeutics?

Breath Therapeutics was owned by Sofinnova Partners through Sofinnova Capital VIII (2015 vintage) from 2016 to 2019, exited via Trade Sale. Across its history, Breath Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital VIII · 2015 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQGermany
SectorHealthcare / Biotech
Key takeaways
  • ·Fully exited in 2019.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2019 to .
Co-invest · 2 holders · 2016 · 2019
Sofinnova Partners
Sofinnova PartnersExited 2019
2016 · 2019 · Sofinnova Capital VIII · 2015 · Life Sciences VC
Trade Sale · to
MOIC
–
Gimv
GimvExited 2019
2016 · 2019 · Gimv Portfolio
Trade Sale · to
MOIC
–

More from Sofinnova Capital VIII

Other portfolio companies in the same fund.

VectivBio
Exited 2023
BiotechSwitzerland· 2017
to
Corvidia Therapeutics
Exited 2020
BiotechUS· 2016
to
Delinia
Exited 2017
BiotechUK· 2016
to
ENYO Pharma
Active
BiotechFrance· 2016
ReCor Medical
Exited 2018
MedTechUS· 2016
to
BiovelocITA
Active
BiotechItaly· 2015

More PE-backed in Biotech

Comparable biotech deals from other GPs.

InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings